Invention Grant
US08211445B2 PSM peptides as vaccine targets against methicillin-resistant Staphylococcus
有权
PSM肽作为抗甲氧西林耐药葡萄球菌的疫苗靶点
- Patent Title: PSM peptides as vaccine targets against methicillin-resistant Staphylococcus
- Patent Title (中): PSM肽作为抗甲氧西林耐药葡萄球菌的疫苗靶点
-
Application No.: US12631253Application Date: 2009-12-04
-
Publication No.: US08211445B2Publication Date: 2012-07-03
- Inventor: Michael Otto , Rong Wang
- Applicant: Michael Otto , Rong Wang
- Applicant Address: US DC Washington
- Assignee: The United States of America, as represented by the Department of Health and Human Services
- Current Assignee: The United States of America, as represented by the Department of Health and Human Services
- Current Assignee Address: US DC Washington
- Agency: Klarquist Sparkman, LLP.
- Main IPC: A61K39/085
- IPC: A61K39/085
Abstract:
This disclosure concerns compositions and methods for the treatment and inhibition of infectious disease, particularly methicillin-resistant Staphylococcus. In certain embodiments, the disclosure concerns immunogenic peptides, for instance PSM peptides, which can be used to induce protective immunity against methicillin-resistant Staphylococcus. Also disclosed are methods of detecting methicillin-resistant staphylococcus in a sample, and methods of diagnosing methicillin-resistant staphylococcus in a subject.
Public/Granted literature
- US20100119477A1 PSM PEPTIDES AS VACCINE TARGETS AGAINST METHICILLIN-RESISTANT STAPHYLOCOCCUS Public/Granted day:2010-05-13
Information query
